Showing posts with label guidances. Show all posts
Showing posts with label guidances. Show all posts

Wednesday, July 6, 2022

FDA Issues Two DSCSA Draft Guidances

The FDA issued 2 DSCSA draft guidances:

Date PublishedTypeTitle
7/05/2022Draft GuidanceIdentifying Trading Partners Under the Drug Supply Chain Security Act
7/05/2022Draft GuidanceDSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs Guidance for Industry

View the full list of Drug Supply Chain Security Act Law and Policies - FDA.gov

Return Home:  The Designated Representative and Exemptee Blog

- - - 

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Thursday, January 21, 2016

DSCSA Regulations & Guidances From The FDA Are Overdue

Updated Nov 26, 2019.  You might also be interested in:
- - -  the original post follows below  - - -

This should interest wholesale drug distributors and third-party logistics providers (3PLs).

A total of four DSCSA regulations and guidances were expected from the FDA by November 27, 2015 (Source: Drug Supply Chain Security Act (DSCSA) Implementation Plan; view the text version of the graphic):

Section of DSCSA

Deliverable Type

Deliverable Description

Estimated Target Date

202
Guidance
Publish guidance on processes for waivers, exceptions, exemptions
11/27/2015
202
Guidance
Publish final guidance on grandfathering product
11/27/2015
204
Regulation
Develop regulations establishing standards for licensing of wholesale drug distributors
11/27/2015
205
Regulation
Develop regulations establishing standards for licensing of third-party logistic providers
11/27/2015





Return Home:  The Designated Representative and Exemptee Blog

------------------


For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Tuesday, February 17, 2015

FDA issues new draft documents related to compounding of human drugs

Updated November 24, 2020

Links broke in the original post.

You'll be interested in:

- - -  original post follows below  - - -

Read the full press release, and find links to the guidances:
Press Announcements > FDA issues new draft documents related to compounding of human drugs - FDA.gov:

"Documents include draft guidances on outsourcing facility registration; outsourcing facility adverse event reporting; drug repackaging; mixing, diluting, and repackaging biological products; and a draft Memorandum of Understanding with the states"

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Custom Search

From SkillsPlus International Inc.